OWKIN K Trademark

Downloadable or recorded databases in the fields of medical and biomedical research and development, medical diagnosis and treatment, clinical trials, and drug discovery and development; downloadable or recorded software for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; downloadable or recorded software for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; downloadable or recorded application software for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; downloadable or recorded application software for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; scientific laboratory research devices for DNA analysis, namely, for analyzing genome information; downloadable or recorded artificial intelligence software for healthcare, namely, diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; downloadable or recorded artificial intelligence software for healthcare, namely, for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; downloadable or recorded computer application software for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; downloadable or recorded computer application software for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; downloadable or recorded computer software for database management; software as a medical device (SAMD), downloadable, for diagnosing medical conditions, prescribing medical treatment and prescriptions, and searching for clinical trial patients; downloadable or recorded computer software development tools; computer software platforms, recorded or downloadable, for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; computer software platforms, recorded or downloadable, for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; computer programs, recorded, for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; computer programs, recorded, for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; electronic publications, downloadable, in the nature of books, magazines, brochures, newsletters, scientific reports, scientific journals, conference proceedings and journals in the fields of medical and biomedical research and development, medical diagnosis and treatment, clinical trials, and drug discovery and development; interfaces for computers; cloud network servers

Telecommunication services, namely, transfer of data by telecommunications; computer intercommunication by computer terminals; communications by computer terminals; computer aided electronic transmission of messages, information and images; transmission of data and information by computer and electronic communication means; communications between data banks by computer terminals; electronic data interchange services; providing multiple-user access to a global computer information network; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; transmission of electronic mail; rental of access time to a computer database on a global computer network; provision of telecommunications access to online databases and the Internet

Software as a service (SAAS) services featuring software for diagnosing medical conditions, prescribing medical treatment and prescriptions, researching the clinical trial landscape and data, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds; Software as a service (SAAS) services featuring software for prioritizing targets, assessing tractability and drugability, characterizing patient subgroups, generating reports, validating biomarkers across modalities, and connecting biology to clinical outcomes; scientific and technological services; medical research; scientific research in the medical and biomedical fields